Hancock Whitney’s Bausch Health BHC Stock Holding History

Hancock Whitney’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-65,314	Closed	-$1.8M	–	689
2021 Q4	$1.8M	Sell	65,314 -1,686	-3%	-$45.1K	0.06%	260
2021 Q3	$1.87M	Buy	67,000 +593	+0.9%	+$16.8K	0.07%	238
2021 Q2	$1.95M	Buy	66,407 +536	+0.8%	+$16.2K	0.06%	285
2021 Q1	$2.09M	Buy	+65,871	New	+$1.93M	0.07%	263

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

GCC

Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Hancock Whitney's BHC Position: Q1 2022 in Review

Hancock Whitney sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 65,314 shares — an estimated $1.8M sold.

Hancock Whitney first reported a position in BHC in Q1 2021 and held it in 4 quarters. The position peaked at $2.09M in Q1 2021. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

Hancock Whitney reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
Hancock Whitney sold 65,314 Bausch Health shares in Q1 2022, an estimated $1.8M.
Hancock Whitney first reported a position in Bausch Health in Q1 2021 and held it in 4 quarters.
Hancock Whitney's Bausch Health position peaked at $2.09M in Q1 2021.
370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Hancock Whitney's 13F filing for Q1 2022, filed 12 May 2022.